1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Diagnostics Focus JANUARY 2017

Diagnostics Focus JANUARY 2017

  • January 2017
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Roche Diagnostics Will Focus On In-House NGS Technology
Industry Brief - ITL BioMedical/bioMerieux Sign Distribution Pact For SCU
Industry Brief - Sysmex, Astellas And Daiichi Sankyo Sign MoU To Create Method For Analysing CTC
Industry Brief - Biocartis/Amgen Expand RAS Biomarker Testing Collaboration
Industry Brief - Bayer/Leica To Co-Develop RNAscope Companion Diagnostic Cancer Test
Industry Brief - BI/Rainbow Scientific To Co-Promote Cytogenetic Products
Industry Trend Analysis - Abbott-Alere Merger Feud Prolonged
Industry Brief - Trovagene Completes Reorganisation To Accelerate Global Distribution Of Liquid Biopsy Technology
Industry Trend Analysis - Siemens' US Diagnostic Manufacturing Expansion To Facilitate Growth
Industry Brief - Takara To Acquire Rubicon Genomics
Industry Brief - Grifols To Buy Hologic's Share Of NAT Donor Screening Unit
Industry Brief - Agilent To Acquire Multiplicom
Industry Brief - Premaitha Reports Conditional Takeover Of Yourgene Bioscience
Industry Brief - BIT Group Opens IVD-Focused Contract Manufacturing Facility In China
Industry Brief - Diagnostics 510(k) Clearances - December 2016
Industry Brief - HiberGene's HG C. Difficile Test Granted European Marketing Approval
Industry Brief - Protagen Launches NavigAID SSc Assay In Germany
Industry Brief - Cepheid's Xpert MRSA NxG Test Granted FDA Clearance
Industry Brief - Roche Launches cobas CT/NG On The cobas 6800/8800 Systems
Industry Brief - VolitionRx' Nu.Q Colorectal Cancer Screening Test Gains CE Mark
Industry Brief - FDA Grants PMA Approval For Hologic's Aptima HIV-1 Quant Assay
Industry Brief - Luminex Secures FDA Clearance For ARIES GBS Assay
Industry Brief - CellMax-LBx Liquid Biopsy ctDNA Blood Test Now Available In India
Industry Brief - Roche Gains FDA Clearance For Elecsys AMH Fertility Assay
Industry Brief - Waters MassTrak Vitamin D Solution Granted CE Marking
Industry Brief - Interpace Launches ThyGenX/ThyramiR Combination Thyroid Test Study In US
Industry Trend Analysis - Breast Cancer To Benefit From Increased Pharmaceutical/Diagnostic Synergies
Industry Trend Analysis - Precision Medicine Will Aid Shifting Autoimmune Treatment Landscape
Industry Brief - Diagnostic Conferences - January 2017

Table Of Contents

Diagnostics Focus JANUARY 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.